Healthcare (Prescription Drugs)

in committee · Missouri · House May 15, 2026

HB 1852: Creates provisions relating to pharmacists' authority to dispense insulin

HB 1852 (Missouri House Bill 1852) modifies pharmacy law to explicitly allow pharmacists to dispense an emergency supply of insulin without a new prescription. This provision directly affects patients facing urgent insulin shortages and pharmacists who can now provide this emergency service under new rules. The key mechanism establishes that pharmacists may dispense an emergency insulin supply under Section 338.740, addressing immediate access needs when a patient cannot obtain a new prescription promptly. The bill does not change routine insulin dispensing but creates a specific emergency protocol for pharmacists.

Topics ✓ HealthcareSupports HealthcareEnables pharmacists to dispense emergency insulin without new prescriptions, directly improving patient access to critical medication during shortages.95% confidence

Sub-Topics Prescription Drugs

Track

in committee · Missouri · Senate Jan 15, 2026

SB 1156: Enacts provisions relating to insurance coverage for prescription insulin drugs

SB 1156 would require health insurance plans to cover prescription insulin with limited out-of-pocket costs for policyholders. It directly affects individuals with diabetes who rely on insulin, aiming to reduce their financial burden. The key provision would limit how much patients pay per insulin prescription, though specific cost thresholds aren't detailed in the abstract. The bill is pending review by the Senate Insurance and Banking Committee and has not yet been voted on. This legislation focuses on improving access to a critical medication through insurance coverage requirements.

Topics ✓ HealthcareSupports HealthcareRequires insurance coverage for insulin with limited out-of-pocket costs, directly reducing financial burden for diabetic patients and improving access to essential medication.95% confidence

Sub-Topics Insurance Prescription Drugs

Track

passed · Missouri · Senate May 15, 2026

SB 984: Modifies provisions relating to pharmacy benefit managers

SB 984 regulates how pharmacy benefit managers (PBMs) and insurers audit Missouri pharmacies. It requires 14 days' notice before audits, limits audits to 25 randomly selected prescriptions per year, and mandates pharmacist consultation for clinical audits. The bill prohibits recouping payments for clerical errors (like typos) and bans PBM compensation based on recovered funds. Pharmacies must be given 30 days to address discrepancies, and audits cannot occur during high-volume month periods without consent. These changes directly affect pharmacies and PBMs operating in Missouri, aiming to standardize audit practices and prevent unfair financial penalties.

Topics ✓ HealthcareSupports HealthcareBill protects pharmacies from unfair PBM audits, prohibits recouping clerical errors, and ensures timely dispute resolution, strengthening provider access and patient care within healthcare services.95% confidence

Sub-Topics Prescription Drugs

Track

in committee · Missouri · House May 15, 2026

HB 1978: Removes the expiration date for the RX cares for Missouri program

HB 1978 removes the expiration date for Missouri's RX Cares program, making it permanent. The program, administered by the Missouri Board of Pharmacy, focuses on promoting medication safety and preventing prescription drug abuse through funding for education and community programs. It allows the Board to allocate funds to private or public entities for these purposes, while prohibiting use of funds for state prescription drug monitoring systems. The bill eliminates the previous requirement that the program end on August 28, 2026, ensuring ongoing operation without sunset provisions.

Topics ✓ HealthcareSupports HealthcarePermanently funds RX Cares program for medication safety/abuse prevention under Health and Senior Services, directly advancing public health initiatives through sustained education funding.95% confidence

Sub-Topics Prescription Drugs

Track

in committee · Missouri · Senate Feb 4, 2026

SB 1178: Enacts requirements for certain reporting regarding the federal 340B drug program

SB 1178 requires Missouri hospitals participating in the federal 340B Drug Pricing Program to submit annual financial reports by April 1st. These reports detail drug acquisition costs, payments received, savings from the program, and how savings are used for charity care or community benefits. Hospitals must also report patient demographics and financial assistance policies, with data categorized by payer type (e.g., Medicaid, uninsured). The state health department will publish aggregated reports by November 15th and impose $1,000 daily penalties for late submissions. This bill increases transparency around how 340B program savings support low-income patient care in Missouri.

Topics ✓ HealthcareSupports HealthcareRequires hospitals to report 340B savings usage for charity care/community benefits, ensuring program funds directly support healthcare access and community health services.90% confidence

Sub-Topics Hospitals Medicaid Prescription Drugs

Track

in committee · Missouri · House May 15, 2026

HB 2081: Creates provisions relating to reporting requirements for entities that participate in the 340B drug pricing program

HB 2081 requires Missouri-based entities participating in the federal 340B drug pricing program (which provides discounted medications to safety-net hospitals and clinics) to submit detailed annual reports to the state Department of Health and Senior Services by April 1st. The reports must include specific financial data on drug acquisition costs, payments received, charity care expenses, and how savings from the program are used. Entities failing to submit on time face daily fines of $1,000. The department will then compile and publicly share aggregated data annually, while keeping individual entity reports confidential. This bill directly affects Missouri hospitals, clinics, and outpatient facilities that operate under the federal 340B program.

Topics ✓ HealthcareSupports HealthcareRequires transparency for 340B program to ensure savings benefit safety-net providers, strengthening access to discounted medications for vulnerable populations.90% confidence

Sub-Topics Prescription Drugs

Track

in committee · Missouri · Senate Jan 27, 2026

SB 1327: Creates provisions relating to cost-sharing under health benefit plans

SB 1327 requires health insurance plans and pharmacy benefit managers to count all medication costs (when a generic drug isn't available) toward an enrollee's annual out-of-pocket maximum. It prohibits plans from adjusting cost-sharing requirements based on whether assistance programs exist for non-generic drugs. This directly affects individuals enrolled in health benefit plans who take medications without generic alternatives. The law ensures these medication costs fully count toward coverage limits, providing clearer cost transparency for enrollees.

Topics ✓ HealthcareSupports HealthcareRequires all medication costs (non-generic) count toward out-of-pocket max, preventing insurers from excluding these costs and expanding patient access to full coverage.95% confidence

Sub-Topics Insurance Prescription Drugs

Track

in committee · Missouri · House May 15, 2026

HB 2260: Creates provisions relating to pharmacists' authority to dispense insulin

HB 2260 would allow pharmacists to dispense an emergency supply of insulin to patients without a new prescription when a patient's regular insulin supply is unavailable. This change directly affects pharmacists, who would gain this specific authority, and patients facing urgent insulin shortages. The bill creates a new provision (section 338.740) that permits pharmacists to provide this emergency supply under defined conditions. The measure aims to improve immediate access to critical insulin medication during temporary shortages.

Topics ✓ HealthcareSupports HealthcareAllows pharmacists to provide emergency insulin access during shortages, improving patient access to critical medication without new prescriptions.95% confidence

Sub-Topics Prescription Drugs

Track

in committee · Missouri · Senate Feb 5, 2026

SB 1449: Enacts provisions relating to insurance coverage of alternatives to opioid drugs

SB 1449 would require health insurance plans to cover non-opioid alternatives for pain management, such as physical therapy or certain medications. This bill directly affects insurance companies, which would need to provide this coverage, and patients seeking pain treatment without opioids. The key provision mandates that insurers treat these non-opioid options with the same coverage terms as opioid medications. The bill aims to expand access to safer pain management options through insurance coverage.

Topics ✓ HealthcareSupports HealthcareMandates insurance coverage for non-opioid pain management alternatives, expanding patient access to safer treatments and requiring equal coverage terms as opioids.95% confidence

Sub-Topics Insurance Prescription Drugs Substance Abuse

Track

in committee · Missouri · House Apr 29, 2026

HB 1941: Creates provisions relating to cost-sharing under health benefit plans

HB 1941 requires health insurance plans in Missouri to count payments for non-generic medications toward a patient's annual out-of-pocket maximum. Specifically, health carriers must include costs paid by enrollees for medications where a generic version is unavailable when calculating this limit. The bill also prohibits plans from adjusting cost-sharing requirements based on the availability of cost-assistance programs for such medications. This directly affects patients using non-generic prescription drugs who would otherwise face unexpectedly high out-of-pocket expenses. The law applies to most health benefit plans starting August 28, 2026.

Topics ✓ HealthcareSupports HealthcareRequires insurers to count non-generic drug costs toward out-of-pocket max, preventing patients from exceeding limits when generics unavailable, protecting financial burden.95% confidence

Sub-Topics Insurance Prescription Drugs

Track